Cited by 1,007Schizophrenia research and treatmentPsychometric Methodologies and TestingPsychological Testing and Assessment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, Stanley R., Opler, Lewis A., Lindenmayer, Jean-Pierre·1988·Psychiatry Research

DOI 10.1016/0165-1781(88)90038-8

Open this paper in CoChat — free account

Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings.

Integrity signals

Registry

Crossref · 10.1016/0165-1781(88)90038-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Positive and negative symptoms in schizophrenia
Rosen, W. G., Mohs, R. C., Johns, C. A., Small, N. S., Kendler, K. S., Horvath, T., & Davis, K. L. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90075-1 · Cited by 238

Show all 28 references

Research works printed but not linked: 1

Kay, 1981, Arousal in schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11, 35

Sorted by citations

Items 201–300 of 998

The effects of focus of attention on attributional bias in patients experiencing auditory hallucinations
Ensum, I., & Morrison, A. P. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(02)00102-x · Cited by 57
Relationship between childhood trauma, mindfulness, and dissociation in subjects with and without hallucination proneness
Perona-Garcelán, S., García-Montes, J. M., Rodríguez-Testal, J. F., López-Jiménez, A. M., Ruiz-Veguilla, M., Ductor-Recuerda, M. J., Benítez-Hernández, M. D. M., Arias-Velarde, M. Á., Gómez-Gómez, M. T., & Pérez-Álvarez, M. (2014) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2013.821433 · Cited by 53
“Studies done by Kilcommons and Morrison (2005) and Perona-Garcelán et al. (2008; Perona-Garcelán, Carrascoso-López, et al. 2012; Perona-Garcelán, García-Montes, Ductor-Recuerda, et al. 2012) on subjects with psychosis and by Morrison and Petersen (2003), Varese et al. (2011), and Perona-Garcelán, García-Montes, Rodríg…”
MethodResultInfluential
Theta burst transcranial magnetic stimulation for the treatment of auditory verbal hallucinations: results of a randomized controlled study.
Kindler, J., Homan, P., Flury, R., Strik, W., Dierks, T., & Hubl, D. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.029 · Cited by 52
Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study
Fountoulakis, K. Ν., Dragioti, E., Antonis, T., Wikilund, T., Atmatzidis, X., Nimatoudis, I., Thys, E., Wampers, M., Hranov, L. G., Hristova, T., et al. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz053 · Cited by 54
Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes
Renard, D., Geys, H., Molenberghs, G., Burzykowski, T., & Buyse, M. E. (2002) · Biometrical Journal · doi:10.1002/bimj.200290004 · Cited by 54
Postpsychotic Posttraumatic Stress Disorder
White, R. G., & Gumley, A. I. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181bea625 · Cited by 54
The relationship between metacognitive beliefs, auditory hallucinations, and hallucination‐related distress in clinical and non‐clinical voice‐hearers
Hill, K., Varese, F., Jackson, M. C., & Linden, D. E. J. (2012) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.2012.02039.x · Cited by 53
Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia
Fan, X., Henderson, D. C., Nguyen, D. D., Cather, C., Freudenreich, O., Evins, A. E., Borba, C. P. C., & GOFF, D. C. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.10.012 · Cited by 57
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?
Schennach-Wolff, R., Jäger, M., Mayr, A. J., Meyer, S., Kühn, K.-U., Klingberg, S., Heuser, I., Klosterkötter, J., Gastpar, M., Schmitt, A., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.10.003 · Cited by 53
Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia
Desmarais, J. E., Beauclair, L., Annable, L., Bélanger, M., Kolivakis, T., & Margolese, H. C. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314553611 · Cited by 52
Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS)
Müller, M. J., Rossbach, W., Marx-Dannigkeit, P., Muller-Siecheneder, F., Szegedi, A., & Wetzel, H. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00051-6 · Cited by 53
Influence of cognition and symptoms of schizophrenia on IADL performance
Lipskaya‐Velikovsky, L., Jarus, T., & Kotler, M. (2010) · Scandinavian Journal of Occupational Therapy · doi:10.3109/11038128.2010.490879 · Cited by 51
Decreased Plasma Antioxidants in Schizophrenia
Pae, C., Paik, I., Lee, C., Lee, S.-J., Kim, J.-J., & Lee, C. (2004) · Neuropsychobiology · doi:10.1159/000077942 · Cited by 52
Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale
Schennach, R., Obermeier, M., Seemüller, F., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2012) · Psychopathology · doi:10.1159/000336729 · Cited by 53
NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia
Karle, J., Lublin, H., Gerlach, J., Clemmesen, L., Hansen, L., Andersen, M. Ø., Andersen, J., Fensbo, C., Sloth-Nielsen, M., & Skrumsager, B. K. (1995) · Psychopharmacology · doi:10.1007/bf02246071 · Cited by 52
Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study
Wang, M., Hou, R. H., Jia, J., Mi, G., Qiu, H.-M., Cao, B., & Tang, M. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2387 · Cited by 51
A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: A 6-month follow-up analysis
McKibbin, C. L., Golshan, S., Griver, K., Andren, K. A. K., & Wykes, T. L. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.039 · Cited by 51
Use of NON-PARAMETRIC Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)
Khan, A., Lewis, C., & Lindenmayer, J. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-178 · Cited by 51
A Longitudinal Study of Learning Potential and Rehabilitation Outcome in Schizophrenia
Watzke, S., Brieger, P., Kuß, O., Schoettke, H., & Wiedl, K. H. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.3.248 · Cited by 51
Would a Switch From Typical Antipsychotics to Risperidone Be Beneficial for Elderly Schizophrenic Patients? A Naturalistic, Long-Term, Retrospective, Comparative Study
Barak, Y., Shamir, E. Z., & Weizman, R. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00003 · Cited by 51
Neuropsychophysiological Study of Children at Risk for Schizophrenia: A Preliminary Report
Hendren, R. L., Hodde-Vargas, J., Yeo, R. A., Vargas, A., Brooks, W. M., & Ford, C. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199510000-00013 · Cited by 51
Relationship of metacognition, absorption, and depersonalization in patients with auditory hallucinations
Perona‐Garcelán, S., García‐Montes, J. M., Ductor‐Recuerda, M. J., Vallina‐Fernández, O., Cuevas‐Yust, C., Pérez‐Álvarez, M., Salas‐Azcona, R., & Gómez‐Gómez, M. T. (2012) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.2011.02015.x · Cited by 50
Effects of Dopamine D2/D3 Blockade on Human Sensory and Sensorimotor Gating in Initially Antipsychotic-Naive, First-Episode Schizophrenia Patients
Düring, S. W., Glenthoj, B. Y., Andersen, G. S., & Oranje, B. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.152 · Cited by 50
Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study
Edwards, C., Cella, M., Emsley, R., Tarrier, N., & Wykes, T. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.040 · Cited by 50
Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study
Zhang, X.-Y., Zhou, D. F., Cao, L., Zhang, P.-Y., Wu, G. Y., & Shen, Y. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200111000-00002 · Cited by 50
Fluvoxamine as an Adjunctive Agent in Schizophrenia
Silver, H. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00200.x · Cited by 50
Psychotic Depression and Suicidal Behavior
Fredriksen, K. J., Schoeyen, H. K., Johannessen, J. O., Walby, F. A., Davidson, L., & Schaufel, M. A. (2017) · Psychiatry · doi:10.1080/00332747.2016.1208002 · Cited by 51
A brief intervention to improve exercising in patients with schizophrenia: a controlled pilot study with mental contrasting and implementation intentions (MCII)
Sailer, P., Wieber, F., Pröpster, K., Stoewer, S., Nischk, D., Volk, F., & Odenwald, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0513-y · Cited by 60
Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone
Riedel, M. J., Schennach-Wolff, R., Musil, R., Dehning, S., Cerovecki, A., Opgen-Rhein, M., Matz, J., Seemüller, F., Obermeier, M., Engel, R. R., et al. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1101 · Cited by 49
A Preliminary Exploration of Trauma, Dissociation, and Positive Psychotic Symptoms in a Spanish Sample
Garcelán, S. P., García‐Montes, J. M., Cuevas‐Yust, C., Álvarez, M. P., Ductor-Recuerda, M. J., Salas‐Azcona, R., & Gómez-Gómez, M. T. (2010) · Journal of Trauma & Dissociation · doi:10.1080/15299731003786462 · Cited by 48
Application of the Comprehensive Assessment of At‐Risk Mental States (CAARMS) to the Japanese population: reliability and validity of the Japanese version of the CAARMS
Miyakoshi, T., Matsumoto, K., Ito, F., Ohmuro, N., & Matsuoka, H. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00118.x · Cited by 48
An early improvement threshold to predict response and remission in first-episode schizophrenia
Schennach-Wolff, R., Seemüller, F., Mayr, A. J., Maier, W., Klingberg, S., Heuser, I., Klosterkötter, J., Gastpar, M., Häfner, H., Sauer, H., et al. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.069328 · Cited by 48
Effects of transcranial direct current stimulation on working memory and negative symptoms in schizophrenia: a phase II randomized sham-controlled trial
Gomes, J. S., Trevizol, A. P., Ducos, D. V., Gadelha, A., Ortiz, B. B., Fonseca, A. O., Akiba, H. T., de Azevedo, C. C., Guimarães, L. S. P., Shiozawa, P., et al. (2018) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2018.02.003 · Cited by 48
Culturally adapted Family Intervention (CaFI) for African-Caribbean people diagnosed with schizophrenia and their families: a mixed-methods feasibility study of development, implementation and acceptability
Edge, D., Degnan, A., Cotterill, S., Berry, K., Baker, J. A., Drake, R., & Abel, K. M. (2018) · Health Services and Delivery Research · doi:10.3310/hsdr06320 · Cited by 51
Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia
Pae, C., Yu, H.-S., Kim, J.-J., Lee, C., Lee, S.-J., Jun, T., Lee, C., & Paik, I. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004419 · Cited by 48
Study of Sexuality-Related Characteristics in Young Adults With Schizophrenia Treated With Novel Neuroleptics and in a Comparison Group of Young Adults
Fortier, P., Mottard, J., Trudel, G. A., & Even, S. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007028 · Cited by 48
Rumination, depressive symptoms and awareness of illness in schizophrenia.
Thomas, N., Ribaux, D., & Phillips, L. J. (2014) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812000884 · Cited by 47
Repeated measurements of cerebral blood flow in the left superior temporal gyrus reveal tonic hyperactivity in patients with auditory verbal hallucinations: a possible trait marker
Homan, P., Kindler, J., Hauf, M., Walther, S., Hubl, D., & Dierks, T. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00304 · Cited by 50
Abnormalities of regional homogeneity and its correlation with clinical symptoms in Naïve patients with first-episode schizophrenia
Zhao, X., Yao, J., Lv, Y., Zhang, X., Han, C., Chen, L., Ren, F., Jin, Z., Li, Y., & Sui, Y. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9882-4 · Cited by 47
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues
Bonaccorso, S., Metastasio, A., Ricciardi, A., Stewart, N., Jamal, L., Rujully, N.-U.-D., Theleritis, C. G., Ferracuti, S., Ducci, G., & Schifano, F. (2018) · Brain Sciences · doi:10.3390/brainsci8070133 · Cited by 46
Predictors of quality of life among individuals with schizophrenia
Suttajit, S., & Pilakanta, S. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s81024 · Cited by 46
The development and implementation of an individualised early signs monitoring system in the prediction of relapse in schizophrenia
Tait, A., McNay, L., Gumley, A. I., & O’Grady, M. (2002) · Journal of Mental Health · doi:10.1080/096382301200041551 · Cited by 46
Stability in schizophrenia symptoms over time: Findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study.
Reichenberg, A., Rieckmann, N., & Harvey, P. D. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.3.363 · Cited by 46
Trial design issues and treatment effect modeling in multi‐regional schizophrenia trials
Chen, Y., Wang, S., Khin, N. A., Hung, H., & LAUGHREN, T. P. (2010) · Pharmaceutical Statistics · doi:10.1002/pst.439 · Cited by 46
Self-attacking and self-reassurance in persecutory delusions: A comparison of healthy, depressed and paranoid individuals
Hutton, P., KELLY, J. A., Lowens, I., Taylor, P. J., & Tai, S. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.08.010 · Cited by 49
Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users
Fan, N., Xu, K., Ning, Y., Rosenheck, R. A., Wang, D., Ke, X., Ding, Y., Sun, B., Zhou, C., Deng, X., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.023 · Cited by 46
Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
Lee, J. G., Lee, S. W., Lee, B. J., Park, S. W., Kim, G. M., & Kim, Y. H. (2012) · Psychiatry Investigation · doi:10.4306/pi.2012.9.2.166 · Cited by 46
Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods
Pawełczyk, T., Grancow-Grabka, M., Kotlicka‐Antczak, M., Trafalska, E., Gębski, P., Szemraj, J., Żurner, N., & Pawełczyk, A. M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0473-2 · Cited by 45
Reliability of a standardized and expanded Brief Psychiatric Rating Scale: a replication study
Hafkenscheid, A. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03464.x · Cited by 45
Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia
Dondé, C., Martı́nez, A., Kantrowitz, J. T., Silipo, G. S., Dias, E. C., Patel, G. H., Sanchez‐Peña, J., Corcoran, C. M., Medalia, A. A., Saperstein, A. M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0557-8 · Cited by 45
Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression
Welge, J. A., & Keck, P. E. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1299-4 · Cited by 45
Determinants of expressed emotion in mothers of schizophrenia patients
King, S., Ricard, N., Rochon, V., Steiger, H., & Nelis, S. M. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00018-0 · Cited by 45
Schizophrenic patients with depression: Psychopathological profiles and relationship with negative symptoms
Lindenmayer, J., Grochowski, S., & Kay, S. R. (1991) · Comprehensive Psychiatry · doi:10.1016/0010-440x(91)90032-8 · Cited by 45
Predicting outcome of schizophrenia: Significance of symptom profiles and outcome dimensions
Kay, S. R., & Murrill, L. M. (1990) · Comprehensive Psychiatry · doi:10.1016/0010-440x(90)90012-h · Cited by 45
Evaluation of the impact of a psycho-educational intervention for people diagnosed with schizophrenia and their primary caregivers in Jordan: a randomized controlled trial
Hasan, A. A., Callaghan, P., & Lymn, J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0444-7 · Cited by 44
One-year functional outcomes of naturalistically treated patients with schizophrenia
Spellmann, I., Riedel, M. J., Schennach, R., Seemüller, F., Obermeier, M., Musil, R., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.047 · Cited by 43
Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliability
Binder, M. D., Wampers, M., Thys, E., Wieselgren, I., Lindström, E., & Peuskens, J. (2002) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/136515002760276054 · Cited by 44
Neuropsychological Correlates of Violence in Schizophrenia
Lapierre, D., Braun, C. M. J., Hodgins, S., Toupin, J., Léveillée, S., & Constantineau, C. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.2.253 · Cited by 44
Depression, Affect and Negative Symptoms in Schizophrenia
Lindenmayer, J., & Kay, S. R. (1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291629 · Cited by 44
The Treatment of Negative Symptoms: Pharmacological and Methodological Issues
Carpenter, W. T. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298279 · Cited by 44
Pharmacotherapy of first-episode psychosis
Lambert, M., Conus, P., Lambert, T. J. R., & McGorry, P. D. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.5.717 · Cited by 43
Adjunctive Antidepressant Drug Therapies in the Treatment of Negative Symptoms of Schizophrenia
Evins, A. E., & GOFF, D. C. (1996) · CNS Drugs · doi:10.2165/00023210-199606020-00005 · Cited by 43
Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.
Böge, K., Hahne, I., Bergmann, N., Wingenfeld, K., Zierhut, M., Thomas, N., Ta, T. M. T., Bajbouj, M., & Hahn, E. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.008 · Cited by 44
A pilot investigation of the Graduated Recovery Intervention Program (GRIP) for first episode psychosis
Penn, D. L., Uzenoff, S. R., Perkins, D. O., Mueser, K. T., Hamer, R. M., Waldheter, E. J., Saade, S., & Cook, L. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.006 · Cited by 43
The optimisation of experience sampling protocols in people with schizophrenia
Edwards, C., Cella, M., Tarrier, N., & Wykes, T. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.048 · Cited by 42
Schizotypal personality traits and social cognition are associated with childhood trauma exposure
Quidé, Y., Cohen‐Woods, S., O’Reilly, N., Carr, V. J., Elzinga, B. M., & Green, M. J. (2018) · British Journal of Clinical Psychology · doi:10.1111/bjc.12187 · Cited by 43
Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms
Recio-Barbero, M., Segarra, R., Zabala, A., González–Fraile, E., González-Pinto, A. M., & Ballesteros, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.631589 · Cited by 40
Olfactory acuity in the positive and negative syndromes of schizophrenia
Geddes, J. R., Huws, R., & Pratt, P. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90196-s · Cited by 42
Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness
Binder, J., Albus, M., Hubmann, W., Scherer, J., Sobizack, N., Franz, U., Mohr, F., & Hecht, S. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050020 · Cited by 42
Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study
Kim, S., Jhon, M., Kim, J., Smesny, S., Rice, S., Berk, M., Klier, C. M., McGorry, P. D., Schäfer, M. R., & Amminger, G. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151417 · Cited by 41
EEG Source Network for the Diagnosis of Schizophrenia and the Identification of Subtypes Based on Symptom Severity—A Machine Learning Approach
Kim, J.-Y., Lee, H. S., & Lee, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123934 · Cited by 41
A new method for assessing interexaminer agreement when multiple ratings are made on a single subject: applications to the assessment of neuropsychiatric symptomatology
Cicchetti, D. V., Showalter, D. R., & Rosenheck, R. A. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00095-4 · Cited by 41
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
Sacchetti, E., Galluzzo, A., Valsecchi, P., Romeo, F., Gorini, B., & Warrington, L. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.002 · Cited by 41
Overlapping and Distinctive Features of Hypochondriasis and Obsessive–Compulsive Disorder
Neziroglu, F. A., McKay, D., & Yaryura-Tobias, J. A. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(00)00053-0 · Cited by 41
Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms
Edgar, C. J., Blaettler, T., Bugarski‐Kirola, D., Scouiller, S. L., Garibaldi, G. M., & Marder, S. R. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.009 · Cited by 40
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial
Schennach, R., Riedel, M. J., Obermeier, M., Spellmann, I., Musil, R., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., et al. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0528-2 · Cited by 41
Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis
Sengupta, S. M., MacDonald, K., Fathalli, F., Yim, A., Lepage, M., Iyer, S. N., MALLA, A. K., & Joober, R. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.039 · Cited by 40
Investigating brain aging trajectory deviations in different brain regions of individuals with schizophrenia using multimodal magnetic resonance imaging and brain-age prediction: a multicenter study
Zhu, J., Wu, Y., Tsai, S., Lin, C., & Yang, A. C. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02379-5 · Cited by 41
Culturally-adapted Family Intervention (CaFI) for African-Caribbeans diagnosed with schizophrenia and their families: a feasibility study protocol of implementation and acceptability
Edge, D., Degnan, A., Cotterill, S., Berry, K., Drake, R., Baker, J. A., Barrowclough, C., Hughes-Morley, A., Grey, P., Bhugra, D., et al. (2016) · Pilot and Feasibility Studies · doi:10.1186/s40814-016-0070-2 · Cited by 40
Assessing Health Utilities in Schizophrenia
Voruganti, L. N. P., Awad, A. G., Oyewumi, L. K., Cortese, L., Zirul, S., & Dhawan, R. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017030-00005 · Cited by 39
Determinants of occupational and residential functioning in bipolar disorder
Depp, C. A., Mausbach, B. T., Bowie, C. R., Wolyniec, P. S., Thornquist, M. H., Luke, J. R., McGrath, J. A., Pulver, A. E., Harvey, P. D., & Patterson, T. L. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.035 · Cited by 39
A preliminary exploration of predictors of outcome and cognitive mechanisms of change in cognitive behaviour therapy for psychosis in people not taking antipsychotic medication
Morrison, A. P., Turkington, D., Wardle, M., Spencer, H. M., Barratt, S., Dudley, R. E. J., Brabban, A., & Hutton, P. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.12.001 · Cited by 40
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Barnes, T. R. E., Leeson, V. C., Paton, C., Marston, L., Davies, L. M., William, W., Osborn, D., Kumar, R., Keown, P., Zafar, R., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21490 · Cited by 39
Do schizotypy dimensions reflect the symptoms of schizophrenia?
Thomas, E. H. X., Rossell, S. L., Tan, E. J., Neill, E., Rheenen, T. E. V., Carruthers, S. P., Sumner, P. J., Louise, S., Bozaoglu, K., & Gurvich, C. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418769746 · Cited by 43
Schizophrenia-Like Symptoms in Narcolepsy Type 1: Shared and Distinctive Clinical Characteristics
Plazzi, G., Fabbri, C., Pizza, F., & Serretti, A. (2015) · Neuropsychobiology · doi:10.1159/000432400 · Cited by 39
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: Valid predictors of symptomatic response and remission?
Schennach-Wolff, R., Jäger, M., Obermeier, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., Klosterkötter, J., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003690289 · Cited by 39
Chronic psychiatric status and satisfaction with life
Arrindell, W. A., van Nieuwenhuizen, C., & Luteijn, F. (2001) · Personality and Individual Differences · doi:10.1016/s0191-8869(00)00125-2 · Cited by 39
Prolactin, Subjective Well-Being and Sexual Dysfunction: An Open Label Observational Study Comparing Quetiapine with Risperidone
Westheide, J., Cvetanovska, G., Albrecht, C., Bliesener, N., Cooper‐Mahkorn, D., Creutz, C., Hornung, W. P., Klingmüller, D., Lemke, M. R., Maier, W., et al. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00859.x · Cited by 39
COMT158 polymorphism and hostility
Volavka, J., Kennedy, J. L., Ni, X., Czobor, P., Nolan, K. A., Sheitman, B., Lindenmayer, J., Citrome, L., McEvoy, J. P., & Lieberman, J. A. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20149 · Cited by 39
Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects
Yue, W., Kang, G., Zhang, Y., Qu, M., Tang, F., Han, Y., Ruan, Y., Lu, T., Zhang, J., & Zhang, D. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.056 · Cited by 39
Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial
Boonstra, G., Burger, H., Grobbee, D. E., & Kahn, R. S. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.534801 · Cited by 38
Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle
Bech, P. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01445.x · Cited by 38
BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia
Pae, C., Yu, H.-S., Lee, K., Kim, J.-J., Lee, C., Lee, S.-J., Jun, T., Lee, C., & Paik, I. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.009 · Cited by 38
Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia
Pae, C., Kim, T., Kwon, O., Artioli, P., Serretti, A., Lee, S.-J., Lee, S.-J., Lee, C., Paik, I.-H., & Kim, J. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.05.004 · Cited by 38
Atrophy of the Cerebellar Vermis: Relevance to the Symptoms of Schizophrenia
Sandyk, R., Kay, S. R., & Merriam, A. E. (1991) · International Journal of Neuroscience · doi:10.3109/00207459109150694 · Cited by 38
Principal-component analysis of PANSS and SANS - SAPS global ratings in schizophrenic patients
Dollfus, S., Petit, M., Lesieur, P., & Ménard, J.-F. (1991) · European Psychiatry · doi:10.1017/s0924933800003886 · Cited by 38
Depression and anxiety following psychosis: Associations with mindfulness and psychological flexibility
White, R. G., Gumley, A. I., McTaggart, J., Rattrie, L., McConville, D., Cleare, S., & Mitchell, G. (2013) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812000239 · Cited by 37
Early Antipsychotic Response to Aripiprazole in Adolescents With Schizophrenia: Predictive Value for Clinical Outcomes
Correll, C. U., Zhao, J. L., Carson, W. H., Marcus, R. N., McQuade, R. D., Forbes, R. A., & Mankoski, R. E. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.04.018 · Cited by 37
The dynamics of attachment insecurity and paranoid thoughts: An experience sampling study
Sitko, K., Varese, F., Sellwood, W., Hammond, A., & Bentall, R. P. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.08.057 · Cited by 37
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort
Mallet, J., Strat, Y. L., Schürhoff, F., Mazer, N., Portalier, C., Andrianarisoa, M., Aouizerate, B., Berna, F. S., Brunel, L. C., Capdevielle, D., et al. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0873-7 · Cited by 37

Authors: Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Opler, Lewis A.
Lindenmayer, Jean-Pierre
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 1988-01
Volume: 23
Issue: 1
Pages: 99-110
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/0165-1781(88)90038-8
OpenAlex: W2100828552
Cited by: 1,007
References: 28
Citations by year: 2026: 16 · 2025: 30 · 2024: 38 · 2023: 28 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 37 · 2018: 41 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 37 · 2013: 40 · 2012: 44
FWCI: 8.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: PANSS, schizophrenia, psychometric properties, inter-rater reliability, criterion validity, construct validity, positive symptoms, negative symptoms, cross-validation
MeSH terms: Adult, Female, Humans, Male, Prognosis, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks